Fidelity International
ZNTL icon

Fidelity International’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Fidelity International’s Portfolio ZNTL Stock Details ZNTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-129
Closed -$7K – 1127
2020
Q4 		$7K Buy
+129
New +$5.82K ﹤0.01% 816

Other funds holding ZNTL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity International's ZNTL Position: Q1 2021 in Review

Fidelity International sold out of Zentalis Pharmaceuticals (ZNTL) in Q1 2021, closing a stake of 129 shares — an estimated $7K sold.

Fidelity International first reported a position in ZNTL in Q4 2020 and held it in 1 quarter. The position peaked at $7K in Q4 2020. 95 funds tracked by Wall St. Rank hold ZNTL as of Q1 2021.

  • Fidelity International reported no remaining Zentalis Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Fidelity International sold 129 Zentalis Pharmaceuticals shares in Q1 2021, an estimated $7K.
  • Fidelity International first reported a position in Zentalis Pharmaceuticals in Q4 2020 and held it in 1 quarter.
  • Fidelity International's Zentalis Pharmaceuticals position peaked at $7K in Q4 2020.
  • 95 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q1 2021.

Based on Fidelity International's 13F filing for Q1 2021, filed 14 May 2021.